Atlas Trials

Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19

Clinical trial NCT04576728 · COMPLETED

Trial details

NCT number
NCT04576728
Sponsor
Biotest
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Covid19
Start date
2020-10-06
Primary completion
2021-06-29
Enrollment
166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.